CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Henry E. Blair, Chairman and Chief Executive Officer of Dyax, will present at the BIO InvestorForum 2006 being held on October 18-19, at the Palace Hotel in San Francisco, CA. Mr. Blair will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax Corp. presentation is scheduled for Wednesday, October 18 at 10:40 am (PT).
